Fifth indication for seizure drug approved

October 2, 2006

Lamotrigine (Lamictal) has been approved for its fifth indication as an antiepileptic—this time as an add-on therapy to treat primary generalized tonic-clonic seizures in children two years of age and older and adults.

Lamotrigine (Lamictal) has been approved for its fifth indication as an antiepileptic—this time as an add-on therapy to treat primary generalized tonic-clonic seizures in children two years of age and older and adults. The drug is also approved as a maintenance treatment for bipolar I disorder in adults.

To see more Hot off the Press news articles, click here.

To go to the Drug Topics homepage, click here.